South & Central America Veterinary Vaccines Market Analysis and Forecast by Size, Share, Growth, Trends 2031

The South & Central America Veterinary Vaccines Market size is expected to reach US$ 357.1 Million by 2031 from US$ 294.0 Million in 2024. The market is estimated to record a CAGR of 2.8% from 2025 to 2031.

Executive Summary and South & Central America Veterinary Vaccines Market Analysis:

The veterinary vaccines market in South & Central America, comprising Brazil, Argentina, and other regions, accounts for a significant portion of the global market and is expected to grow robustly in the near future. The major driver of this growth is the increasing demand for animal by-products (ex., meat, milk, and eggs), which creates demand for preventing disease in livestock. Ongoing innovation by manufacturers in vaccinations (to improve effectiveness, safety, and delivery) will also support growth. Government initiatives to enhance animal health, advance vaccine research, and enhance veterinary services and healthcare are also supportive of growth. Brazil and Argentina are significant livestock producers and are also witnessing advances in the pet care and pet products markets, both of which are expected to drive growth in vaccination and animal health. Other areas of South & Central America are increasing focus on modern veterinary healthcare, particularly in traditional livestock production.

South & Central America Veterinary Vaccines Market: Strategic Insights

South & Central America Veterinary Vaccines Market Segmentation Analysis:

• By Technology, the South & Central America Veterinary Vaccines Market is segmented into Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Others. Live Attenuated Vaccines held the largest share of the market in 2024.
• By Animal Type, the South & Central America Veterinary Vaccines Market is segmented into Companion and Livestock and Poultry. Livestock and Poultry held the largest share of the market in 2024.
• By Companion, the South & Central America Veterinary Vaccines Market is segmented into Dogs, Cat, Horses, and Others. Dogs held the largest share of the market in 2024.
• By Livestock and Poultry, the South & Central America Veterinary Vaccines Market is segmented into Chicken, Cattle, and Others. Chicken held the largest share of the market in 2024.
• By Route of Administration, the South & Central America Veterinary Vaccines Market is segmented into Intramuscular, Subcutaneous, and Others. Intramuscular held the largest share of the market in 2024.
• By End User, the South & Central America Veterinary Vaccines Market is segmented into Veterinary Hospitals, Veterinary Clinics, and Others. Veterinary Hospitals held the largest share of the market in 2024.

South & Central America Veterinary Vaccines Market Players Density: Understanding Its Impact on Business Dynamics

The South & Central America Veterinary Vaccines Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

South & Central America Veterinary Vaccines Market Outlook

The increase in manufacturing plants is a significant growth prospect for the veterinary vaccines market. It solves pressing issues, including production scalability, reducing costs, and making vaccines more accessible regionally. With the soaring demand for veterinary vaccines fueled by increasing pet ownership, livestock husbandry requirements, and international disease prevention programs, producers are spending on new plants and renovating old ones to boost production capacity. In 2025, CDV Laboratorio announced the expansion of its operations in Pilar Industrial Park, Buenos Aires province, with a 26% growth projection for 2025 as part of its strategy to become one of the top 20 global veterinary vaccine labs. The expansion includes the construction of a third plant and a significant investment in new facilities. Also, in 2024, Biogénesis Bagó (Argentina/Brazil) opened a new vaccine-production plant in Campo Largo, Brazil, with an investment of around US$ 30 million. The facility will have an annual capacity of over 10 million doses and serve both pet and farm animal vaccines.

These expansions add supply to address worldwide demand and reduce the cost of production through economies of scale. Regional manufacturing facilities ensure quicker distribution and lower import reliance, especially in developing countries such as India, Brazil, and Africa. Governments and institutions promote local manufacturing through incentives, which has promoted local production of veterinary products. These investments provide opportunities for efficiency, innovation, and increased vaccine availability.

South & Central America Veterinary Vaccines Market Country Insights

By country, the South & Central America Veterinary Vaccines Market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil held the largest share in 2024.

According to the PAHO, between EW 1 and EW 52 of 2024, 15 outbreaks of avian influenza A(H5) have been confirmed in wild birds in the Brazilian states of Espírito Santo, Rio de Janeiro, Rio Grande do Sul, and São Paulo. The rise in zoonotic diseases like avian influenza and the increasing risk of foot-and-mouth disease (FMD) are driving government initiatives to enhance vaccination campaigns across the country. Brazil's Ministry of Agriculture and Livestock (MAPA) has implemented programs to control and eradicate FMD. Such initiatives by the Government of Brazil are creating opportunities for market players to expand their presence in the country. In July 2024, Biogénesis Bagó, the leading global biotech company in the animal health, productivity, and welfare sector, opened a vaccine production plant in Campo Largo, Brazil, requiring a US$ 30 million investment. Beginning in 2026, the new facility will produce more than 10 million doses of live attenuated virus vaccines each year, initially concentrating on feline trivalent vaccines and canine quintuple/sextuple vaccines, both with and without leptospira.

South & Central America Veterinary Vaccines Market Company Profiles

Some of the key players operating in the market include Merck & Co Inc, Boehringer Ingelheim International GmbH, Ceva Santé Animale, Zoetis Inc, Elanco Animal Health Inc, Virbac SA, Neogen Corp, Hester Biosciences Ltd, HIPRA SA, and Biovac LTD.

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

South & Central America Veterinary Vaccines Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note:

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise